Metagenomi, Inc. (MGX) Dividend History

Metagenomi, Inc. (MGX) is a biotechnology company focused on the development of next-generation gene editing therapies. Leveraging its proprietary platform, the company aims to create precise, safe, and effective genetic treatment solutions for a range of genetic diseases and conditions.

5959 Horton Street, Emeryville, CA, 94608
Phone: (510) 871-4880
Website: https://www.metagenomi.co

Dividend History

Metagenomi, Inc. currently does not pay dividends

Company News

Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025

Metagenomi presented data at the ASGCT Annual Meeting 2025, showcasing advancements in its gene editing technologies, including compact nucleases for extrahepatic gene editing and CAST for site-specific integration of large therapeutic genes.

GlobeNewswire Inc.
Stocks To Watch: Eyes On Broadcom, Target, Costco, Rivian And Small Caps

Stay informed of upcoming IPOs, earnings reports, and market events with Seeking Alpha's Stocks to Watch newsletter.

Seeking Alpha

Featured Companies: AAL AHR AS AVGO MAT RIVN TELO TGT
This Biotech IPO Stock Just Took a Tumble, But Don't Give Up on It Yet

A bumpy start can't detract from this company's strong balance sheet.

The Motley Fool

Page data last updated 07/23/2025 04:52:56 UTC

Metagenomi, Inc. (MGX) Dividend History

Dividend History

Company News

Related Companies